![Tomas L. Lindahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomas L. Lindahl
Director/Miembro de la Junta en
MEDIROX AB
.
Perfil
Tomas L.
Lindahl founded Diapensia HB in 1992, where he is working as Chief Executive Officer from 1992.
Mr. Lindahl also currently works at Nordic Haemostasis AB, as Chairman and MediRox AB, as Independent Director from 2014.
Cargos activos de Tomas L. Lindahl
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIROX AB | Director/Miembro de la Junta | 01/08/2014 |
Diapensia HB | Director Ejecutivo | 01/01/1992 |
Nordic Haemostasis AB | Presidente | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
MediRox AB
 MediRox AB Pharmaceuticals: MajorHealth Technology Develops and markets products for the laboratory diagnosis of circulatory disorders | Health Technology |
Diapensia HB | |
Nordic Haemostasis AB |
- Bolsa de valores
- Insiders
- Tomas L. Lindahl
Elige MarketScreener 
